ArticleBioMed research international2026

SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram.

Jiali Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.